BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia

Leukemia. 2013 Jan;27(1):251-2. doi: 10.1038/leu.2012.199. Epub 2012 Jul 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers, Tumor / genetics*
  • Child
  • Child, Preschool
  • Cohort Studies
  • DNA, Neoplasm / genetics
  • Down Syndrome / complications
  • Down Syndrome / epidemiology
  • Down Syndrome / genetics*
  • Female
  • Follow-Up Studies
  • Gene Deletion*
  • Humans
  • Infant
  • Male
  • Mutation / genetics*
  • Neoplasm Proteins / genetics*
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology*
  • Prognosis
  • Risk Factors
  • Survival Rate
  • Young Adult

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Neoplasm Proteins
  • BTG1 protein, human